Skip to content
‹ Back to IndustriesHealthcare

Saving Lives for a Living: How a Winning Attitude is the Secret

At some point in everyone’s life, a thought passes through the brain that maybe one day they’ll save someone else’s life. For others, that thought becomes so frequent that they take charge of saving lives for a living. Meet Dr. John George, MD, a cardiologist at Methodist Health System, and Dr. Brian Lima, MD,…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

 
At some point in everyone’s life, a thought passes through the brain that maybe one day they’ll save someone else’s life. For others, that thought becomes so frequent that they take charge of saving lives for a living. Meet Dr. John George, MD, a cardiologist at Methodist Health System, and Dr. Brian Lima, MD, the National Physician Director at HCA Healthcare.

These two doctors are experts in cardiology, one of the most specialized areas of medicine. Their medical journey includes long hours, multiple universities during years of education, and fellowships. The path to becoming a life-saving cardiologist takes thirteen years. Is getting into the “saving lives” business worth all the effort? Absolutely.

#WinTheDay host Chase Wasson wanted to learn more about what makes someone who saves lives for a living tick; George and Lima were happy to fill him in on the details.

Wasson also wanted to know what changes they’d seen in the cardiology business over the years. “I don’t think it’s just cardiology and cardiac surgery that’s had a big transition in medicine,” George said. I think medicine, as a whole, has had a big transition. Medicine has become, unfortunately, a business. And you tend to overlook the health portion of it. Hospitals run themselves as businesses; you don’t see a lot of charitable hospitals, and many of them have closed. Medicine is another business.”

Wasson, George, and Lima discussed the following…

● Making a positive impact on healthcare at the corporate level

● Perspectives on what makes a good healthcare partner representative

● Innovative technologies improving cardiology today

“In the narrow field of advanced heart failure, we’ve seen a rapid evolvement of devices for short-term support, so something that can tide someone over who’s in extremis versus more of someone who needs a long-term solution like an artificial heart,” Lima said. “Currently, for the left ventricular assist device, the LVAD, based on the most recent trials, it’s almost on par with an actual heart transplant, which is saying a tremendous amount.”

Brian Lima, MD, is, first and foremost, a cardiac surgeon dedicated to the compassionate delivery of the most advanced heart care. As a recognized authority on surgical therapies for advanced heart failure, he is also very passionate about clinical innovation, research, and education, having published nearly 100 articles in peer-reviewed journals and numerous book chapters and presenting at several national and international conferences. As the National Physician Director for Cardiothoracic Surgery within HCA Healthcare, Lima collaborates with clinicians and administrative leaders across the HCA enterprise to elevate the standard of care for advanced heart failure and cardiogenic shock.

John George, MD, is board certified in interventional cardiology, cardiovascular diseases, and nuclear cardiology. He has authored multiple published articles and has co-authored chapters in textbooks. George has been the principal investigator on several major national and international clinical trials and is researching acute coronary syndromes and heart failure. He is a member of the combined cardiology/surgical team at Methodist Health System and performs transcatheter aortic valve replacements.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

New York City digital health startups raised $1.9 billion in Q3, up 36%

New York City digital health startups raised $1.9 billion in Q3, up 36%

New York City digital health startups raised $1.9 billion in Q3 2026, up 36% year over year. Nationally, Rock Health counted $3.7 billion raised by U.S. digital health startups across 114 deals in the quarter. Bigger checks and steady acquisitions mean buyers must assess which vendors are pulling ahead—and which may change owners mid-rollout.

  • 01New York's digital health startups grew Q3 funding 36% year over year, while U.S. digital health startups raised $3.7 billion across 114 deals in Q3, according to Rock Health.
  • 02Average U.S. digital health deal size has climbed from $20.6 million in 2024 to $31.0 million so far in 2026, so more of the money is going into bigger rounds.
  • 03Acquisition is still how most digital health companies exit, with 164 deals through Q3 2026 and no new public listings since August 2025. That makes a vendor's change-of-ownership terms a live contract question for buyers.

Nov 4, 2026

LeanTaaS buys LookDeep Health and brings computer vision into hospital patient rooms

LeanTaaS buys LookDeep Health and brings computer vision into hospital patient rooms

LeanTaaS said on November 3 it acquired LookDeep Health, a computer vision company, and introduced iQueue for Virtual Care, its first product built on what it calls ambient intelligence. Terms were not disclosed. The product bundles Virtual Observation, Virtual Nursing and Virtual Medicine, and LeanTaaS says hospitals can build on compatible cameras and in-room devices already installed or deploy supported hardware. The company cited reported results from LookDeep deployments, including fall-rate reductions of more than 70%, and said LookDeep's technology was evaluated in peer-reviewed research published in Frontiers in Imaging.

  • 01LeanTaaS acquired LookDeep Health and launched iQueue for Virtual Care, combining Virtual Observation, Virtual Nursing and Virtual Medicine; acquisition terms were not disclosed.
  • 02Hospitals can build on compatible cameras and in-room devices already in place or deploy supported hardware, according to LeanTaaS, which did not name camera vendors.
  • 03LeanTaaS reported results from LookDeep deployments including fall-rate reductions of more than 70% and twice as much nursing contact, figures that are the company's own and not tied to named health systems.

Nov 3, 2026

Philips posts 8% order intake growth in Q3 and books a EUR 288 million Respironics provision

Philips posts 8% order intake growth in Q3 and books a EUR 288 million Respironics provision

Royal Philips reported 8% comparable order intake growth for the third quarter of 2026, driven by Diagnosis & Treatment, with comparable sales up 3% to EUR 4.4 billion and an adjusted EBITA margin of 13.0%, up 70 basis points. The company reiterated its 2026 outlook for 3% to 4.5% comparable sales growth. Philips Respironics reached an agreement in principle with the US Department of Justice to resolve previously disclosed investigations related to its recall, and Philips recorded a EUR 288 million provision in the quarter, with payment expected in the first quarter of 2027 subject to final documentation.

  • 01Comparable order intake grew 8%, matching a year earlier, with Diagnosis & Treatment the driver; the equipment order book stands at about 40% of revenue.
  • 02Comparable sales rose 3% to EUR 4.4 billion, adjusted EBITA margin reached 13.0%, and free cash flow was EUR 384 million; the 2026 outlook was reiterated.
  • 03Philips Respironics reached an agreement in principle with the DOJ on previously disclosed recall investigations, and Philips recorded a EUR 288 million provision; the settlement is subject to final documentation.

Nov 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512